A project with the primary outcome to develop an effective Leishmania major human challenge model with 100% lesion clearance after treatment, with the secondary outcome being to measure immune response parameters and analysis of lesion development.

Funded by

The Team

  • York Biomedical Research Institute, University of York (UK):  Dr Alison Layton, Professor Charles Lacey, Dr Helen Ashwin, Mrs Liz Greensted, Professor Paul Kaye, Dr Vivak Parkash
  • The Hebrew University of Jerusalem (Israel): Professor Charles Jaffe, Professor Eli Schwartz
  • Charles University Prague (Czech Republic): Professor Jovana Sádlová, Professor Petr Volf

For more information please click here.

Posted on:

Comments are closed.